# FDA Inspection 1262093 - Kalyani Khandare, MBBS - February 14, 2025

Source: https://www.keypedia.com/records/fda_inspections/kalyani-khandare-mbbs/a207398e-264e-4b7c-bd9b-2ddf13c24ae1
Source feed: FDA_Inspections

> FDA Inspection 1262093 for Kalyani Khandare, MBBS on February 14, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1262093
- Company Name: Kalyani Khandare, MBBS
- Inspection Date: 2025-02-14
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1262093 - 2025-02-14](https://www.keypedia.com/records/fda_inspections/kalyani-khandare-mbbs/d1ccfd44-a77a-41e2-b4a9-2d787edb8d8d)

Company: https://www.keypedia.com/companies/kalyani-khandare-mbbs/820624e3-68a8-43ab-9a76-bbc9f175f124

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c